MedKoo Cat#: 591103 | Name: ADDA

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ADDA is a non-proteinogenic amino acid found in toxins made by cyanobacteria.

Chemical Structure

ADDA
CAS#126456-06-2

Theoretical Analysis

MedKoo Cat#: 591103

Name: ADDA

CAS#: 126456-06-2

Chemical Formula: C20H29NO3

Exact Mass: 331.2147

Molecular Weight: 331.46

Elemental Analysis: C, 72.47; H, 8.82; N, 4.23; O, 14.48

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ADDA;
IUPAC/Chemical Name
4,6-Decadienoic acid, 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-, (2S-(2R*,3R*,4E,6E,8R*,9R*))-
InChi Key
HJVCHYDYCYBBQX-HLTLHRPFSA-N
InChi Code
InChI=1S/C20H29NO3/c1-14(10-11-18(21)16(3)20(22)23)12-15(2)19(24-4)13-17-8-6-5-7-9-17/h5-12,15-16,18-19H,13,21H2,1-4H3,(H,22,23)/b11-10+,14-12+/t15-,16-,18-,19-/m0/s1
SMILES Code
O=C(O)[C@@H](C)[C@@H](N)/C=C/C(C)=C/[C@H](C)[C@@H](OC)CC1=CC=CC=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 331.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kust A, Urajová P, Hrouzek P, Vu DL, Čapková K, Štenclová L, Řeháková K, Kozlíková-Zapomělová E, Lepšová-Skácelová O, Lukešová A, Mareš J. A new microcystin producing Nostoc strain discovered in broad toxicological screening of non-planktic Nostocaceae (Cyanobacteria). Toxicon. 2018 May 14. pii: S0041-0101(18)30192-2. doi: 10.1016/j.toxicon.2018.05.007. [Epub ahead of print] PubMed PMID: 29772212. 2: Giovati L, Santinoli C, Mangia C, Vismarra A, Belletti S, D'Adda T, Fumarola C, Ciociola T, Bacci C, Magliani W, Polonelli L, Conti S, Kramer LH. Novel Activity of a Synthetic Decapeptide Against Toxoplasma gondii Tachyzoites. Front Microbiol. 2018 Apr 20;9:753. doi: 10.3389/fmicb.2018.00753. eCollection 2018. PubMed PMID: 29731744; PubMed Central PMCID: PMC5920037. 3: Di Palma A, Leone F, Albanese F, Beccati M. A case report of Dermanyssus gallinae infestation in three cats. Vet Dermatol. 2018 Apr 30. doi: 10.1111/vde.12547. [Epub ahead of print] PubMed PMID: 29708634. 4: Pungolino E, Rossi G, De Canal G, Trojani A, D'adda M, Perego A, Orlandi EM, Lunghi F, Turrini M, Borin L, Iurlo A, Latargia ML, Carraro MC, Spina F, Lodola M, Artale S, Anghilieri M, Spedini P, Cantoni S, Di Camillo B, Morra E, Cairoli R. Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia. Am J Hematol. 2018 Apr 10. doi: 10.1002/ajh.25106. [Epub ahead of print] PubMed PMID: 29633310. 5: Polverelli N, Palumbo GA, Binotto G, Abruzzese E, Benevolo G, Bergamaschi M, Tieghi A, Bonifacio M, Breccia M, Catani L, Tiribelli M, D'Adda M, Sgherza N, Isidori A, Cavazzini F, Martino B, Latagliata R, Crugnola M, Heidel F, Bosi C, Ibatici A, Soci F, Penna D, Scaffidi L, Aversa F, Lemoli RM, Vitolo U, Cuneo A, Russo D, Cavo M, Vianelli N, Palandri F. Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients. Hematol Oncol. 2018 Apr 6. doi: 10.1002/hon.2509. [Epub ahead of print] PubMed PMID: 29624703. 6: Kleinteich J, Puddick J, Wood SA, Hildebrand F, Laughinghouse HD IV, Pearce DA, Dietrich DR, Wilmotte A. Toxic Cyanobacteria in Svalbard: Chemical Diversity of Microcystins Detected Using a Liquid Chromatography Mass Spectrometry Precursor Ion Screening Method. Toxins (Basel). 2018 Apr 3;10(4). pii: E147. doi: 10.3390/toxins10040147. PubMed PMID: 29614044; PubMed Central PMCID: PMC5923313. 7: Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6. Epub 2018 Mar 27. PubMed PMID: 29599078. 8: Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, Bonello L, Morel O, Leclercq F, Puymirat E, Ghanem F, Delarche N, Benichou J, Abenhaim L; PGRx-Acute Coronary Syndrome Study Group. Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction. Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534. [Epub ahead of print] PubMed PMID: 29535227. 9: Efficace F, Castagnetti F, Martino B, Breccia M, D'Adda M, Angelucci E, Stagno F, Cottone F, Malato A, Trabacchi E, Capalbo SF, Gobbi M, Visani G, Salvucci M, Capodanno I, Tosi P, Tiribelli M, Scortechini AR, Levato L, Maino E, Binotto G, Gugliotta G, Vignetti M, Baccarani M, Rosti G. Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib. Cancer. 2018 May 15;124(10):2228-2237. doi: 10.1002/cncr.31323. Epub 2018 Mar 2. PubMed PMID: 29499087. 10: Karci A, Wurtzler EM, de la Cruz AA, Wendell D, Dionysiou DD. Solar photo-Fenton treatment of microcystin-LR in aqueous environment: Transformation products and toxicity in different water matrices. J Hazard Mater. 2018 May 5;349:282-292. doi: 10.1016/j.jhazmat.2017.12.071. Epub 2018 Jan 2. PubMed PMID: 29454260. 11: Curinier C, Solecki K, Dupuy AM, Breuker C, Lotierzo M, Zerkowski L, Kalmanovich E, Akodad M, Adda J, Battistella P, Castet-Nicolas A, Kuster N, Marques S, Soltani S, Chettouh M, Verchere A, Belloc C, Roubille C, Fesler P, Mercier G, Cristol JP, Audurier Y, Roubille F. Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial. Contemp Clin Trials. 2018 Mar;66:45-50. doi: 10.1016/j.cct.2018.01.007. Epub 2018 Feb 4. PubMed PMID: 29414143. 12: Mukherjee L, Zhai PW, Hu Y, Winker DM. Single scattering properties of non-spherical hydrosols modeled by spheroids. Opt Express. 2018 Jan 22;26(2):A124-A135. doi: 10.1364/OE.26.00A124. PubMed PMID: 29401902; PubMed Central PMCID: PMC5804889. 13: Danger R, Royer PJ, Reboulleau D, Durand E, Loy J, Tissot A, Lacoste P, Roux A, Reynaud-Gaubert M, Gomez C, Kessler R, Mussot S, Dromer C, Brugière O, Mornex JF, Guillemain R, Dahan M, Knoop C, Botturi K, Foureau A, Pison C, Koutsokera A, Nicod LP, Brouard S, Magnan A; COLT and SysCLAD Consortia. Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome. Front Immunol. 2018 Jan 11;8:1841. doi: 10.3389/fimmu.2017.01841. eCollection 2017. PubMed PMID: 29375549; PubMed Central PMCID: PMC5768645. 14: Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A; OPTIPRIM Study Group . Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial. J Antimicrob Chemother. 2018 Apr 1;73(4):1020-1024. doi: 10.1093/jac/dkx498. PubMed PMID: 29365125. 15: Esnault P, Hraiech S, Bordes J, Forel JM, Adda M, Rambaud R, Lehingue S, Roch A, Papazian L, Guervilly C. Evaluation of Almitrine Infusion During Veno-Venous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome in Adults. Anesth Analg. 2018 Jan 15. doi: 10.1213/ANE.0000000000002786. [Epub ahead of print] PubMed PMID: 29337729. 16: Yang F, Massey IY, Guo J, Yang S, Pu Y, Zeng W, Tan H. Microcystin-LR degradation utilizing a novel effective indigenous bacterial community YFMCD1 from Lake Taihu. J Toxicol Environ Health A. 2018;81(7):184-193. doi: 10.1080/15287394.2018.1423803. Epub 2018 Jan 9. PubMed PMID: 29313451. 17: Wang X, Wang X, Zhao J, Song J, Su C, Wang Z. Surface modified TiO(2) floating photocatalyst with PDDA for efficient adsorption and photocatalytic inactivation of Microcystis aeruginosa. Water Res. 2017 Dec 27;131:320-333. doi: 10.1016/j.watres.2017.12.062. [Epub ahead of print] PubMed PMID: 29306666. 18: Hernu R, Cour M, Argaud L; “Costs in French ICU” Study Group. Are nurses ready to help to improve cost-effectiveness? A multicentric national survey on knowledge of costs among ICU paramedical staff. Intensive Care Med. 2017 Dec 26. doi: 10.1007/s00134-017-5032-5. [Epub ahead of print] PubMed PMID: 29279972. 19: Salmaso F, Crosa G, Espa P, Gentili G, Quadroni S, Zaccara S. Benthic macroinvertebrates response to water management in a lowland river: effects of hydro-power vs irrigation off-stream diversions. Environ Monit Assess. 2017 Dec 20;190(1):33. doi: 10.1007/s10661-017-6390-8. PubMed PMID: 29264669. 20: Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, Capitant C, Rojas-Castro D, Fonsart J, Bercot B, Bébéar C, Cotte L, Robineau O, Raffi F, Charbonneau P, Aslan A, Chas J, Niedbalski L, Spire B, Sagaon-Teyssier L, Carette D, Mestre SL, Doré V, Meyer L; ANRS IPERGAY Study Group. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8. PubMed PMID: 29229440.